Top Markets
#1 Official Trump Official Trump +45.74%
#2 Mubarak Mubarak +25.19%
#3 Melania Meme Melania Meme +22.92%
#4 Movement Movement +21.68%
#5 EXOD EXOD +18.93%
#6 Wrapped POL Wrapped POL +18.07%
#7 Pearl Pearl +17.95%
#8 POL (ex-MATIC) POL (ex-MATIC) +16.59%
#9 Zama Zama +16.47%
#10 Wrapped STX (Velar) Wrapped STX (Velar) +15.99%
Coin of the day
Official Trump Official Trump
Settings
Language
ENGLISH
Currency
USD
Theme
MaaT Pharma S.A. MaaT Pharma S.A.

MaaT Pharma S.A.

MAAT
Rank in Stocks #23616
MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on... MaaT Pharma SA operates as a clinical-stage biotechnology company, focused on the discovery and advancement of microbiome-based biotherapies, primarily for the treatment of solid cancer tumors. Its development pipeline features MaaT013, which has successfully completed Phase 2 clinical trials for acute graft-versus-host disease (aGVHD) and is also undergoing preclinical evaluation for melanoma. Another therapeutic candidate, MaaT033, is currently in Phase 1b clinical trials, aiming to improve survival outcomes for patients with acute myeloid leukemia (AML) or other liquid malignancies following allogeneic hematopoietic stem cell transplantation. Furthermore, MaaT03X is being developed specifically for solid tumor applications. The company was founded in 2014 and maintains its headquarters in Lyon, France.
Share Price
$3.78
Last synced: 2026-08-21
Market Cap
$71.20M
Change (1 day)
2.24%
Change (1 year)
-43.37%
Country
FR
Trade MaaT Pharma S.A. (MAAT)

Category

Healthcare
Earnings for MaaT Pharma S.A. (MAAT)
Earnings in 2026 TTM: 0
According to MaaT Pharma S.A. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for MaaT Pharma S.A. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH